LDS/Medical Tests/Coxsackie B (1-6) Antibodies, (CSF)

Coxsackie B (1-6) Antibodies, (CSF)

The coxsackie group virus are named so as they were isolated from stool samples of children living in Coxsackie, New York in 1948. It has 30 different serotypes that cause different symptoms among children. Serotypes are divided into two groups based on their pathogenicity and antigenicity: Coxsackie A and Coxsackie B. Coxsackie A has 24 serotypes while Coxsackie B has 6 serotypes (B1-B6). The mode of transmission is mainly the fecal-oral route which colonizes in the intestinal tract and later replicates in lymphoid tissues of the nasopharynx.

Coxsackie B virus infections are often asymptomatic or result in an undifferentiated febrile illness. In more serious cases, aseptic meningitis, encephalomyelitis, pleurodynia and/or myocarditis may occur. IgA, IgG and IgM antibodies are produced in response to infection and can be detected in serum and cerebrospinal fluid.

  • Demonstration of Coxsackie B (1-6) antibody in CSF aids in diagnosis of Coxsackie B virus meningitis or encephalomyelitis
Positive antibody titers greater than or equal to 1:80 may indicate current or past infection with Coxsackie B. Demonstration of increased CSF titers over a weeks duration indicate acute infection.

Less 1:1 (in all B1-B6)

Complement fixation test.

Cerebrospinal fluid.

Stability

  • Ambient: 24 hours
  • Refrigerated: 3-5 days
  • Frozen: 30 days
Coxsackie B Antibody Panel – Serum, Coxsackie A9 Virus Antibodies, Coxsackie A Antibodies (A2, A4, A7, A9, A10 and A16), Enterovirus Antibodies Panel, Enterovirus by PCR, Viral Culture.
3-5 Days.
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login